Axogen, Inc. (NASDAQ:AXGN) is among the best medical device stocks to buy, with Raymond James analyst Jayson Bedford lowering the price target to $20 from $21, maintaining an Outperform rating on the shares. The Q2 results showed improved momentum in gross margin and revenue growth.

The company develops surgical solutions for peripheral nerve regeneration and repair, including products like avive soft tissue membrane and axoguard nerve connector. While AXGN shows investment potential, certain AI stocks may offer greater upside potential and less downside risk. Explore more in the free report on the best short-term AI stock.

Read more at Yahoo Finance: Raymond James Slashes PT on Axogen (AXGN) to $20 From $21